Accepted
at 6:29 a.m. Dec, 07, 2024
by
Ahmed7
Author:
saguarocatcus
Type of change:
Updated content
Rationale for change
Capitalization
Before
After
Generic
Generic
Generic
Generic
Brand
Spravato
Info
Class: NMDA receptor antagonist (S-enantiomer of ketamine)
Use: Treatment-resistant depression; administered intranasally; REMS program required
Use: Treatment-resistant depression; administered intranasally; REMS program required
Dosing
Empty field
Adverse Effects
Empty field
Contraindications
Empty field
First Aid
Empty field
Sketchy Pharm
Empty field